6d agoThe Motley FoolBULLISH 73Earnings
Alignment Healthcare (ALHC) Q2 2026 Earnings Call Transcript
Health plan membership surged 31% as AI-powered care coordination drove margin expansion.
Archived explainer. For the current picture see today's ALHC page.
Why Is ALIGNMENT HEALTHCARE (ALHC) Stock Down Today?
By the Top Tier Newswire AI Desk · August 4, 2026 at 6:00 AM ET · reviewed against 3 wire stories
ALIGNMENT HEALTHCARE (ALHC) is down -1.95% in the latest session. Our newswire has captured 3 stories on ALHC across 3 sources in the last 36 hours, with AI sentiment reading bullish (avg 59/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Alignment Healthcare (ALHC) fell 1.95 percent to $14.56 on Wednesday, driven by a downgrade from Raymond James and recent insider selling activity. The stock has declined 26.7 percent over the past eight sessions amid ongoing pressure from mixed earnings visibility and mixed guidance.
What Happened
Raymond James downgraded Alignment Healthcare to Outperform and lowered its price target to $19, citing concerns about earnings visibility. The downgrade came despite the company raising its full-year 2026 sales guidance to a range of $5.195B to $5.225B, which is slightly above the $5.189B estimate. The Q2 earnings report showed strong performance, with EPS of $0.17 beating the $0.13 estimate and revenue of $1.336B exceeding the $1.310B forecast. However, the recent downgrade signals growing skepticism among analysts about the company’s ability to maintain its momentum.
Insider selling has also contributed to the stock's decline. In the past 90 days, 11 insider sales totaling $24.7 million were reported, including transactions from the CEO and other top executives. The most recent insider sale was reported on July 16. In contrast, only one insider buy totaling $198K was recorded during the same period.
What The Data Shows
The stock is currently trading within its 52-week range of $12.91 to $25.12. With a market cap of $3.1 billion and a P/E ratio of 75.2, the stock appears to be trading at a premium despite a net margin of just 0.9 percent. The stock has seen a recent drop of 26.7 percent over the last eight sessions, moving from $21.07 to $15.45. The Q3 sales guidance of $1.300B to $1.320B also reflects a cautious outlook, with the midpoint slightly below the $1.315B estimate.
What To Watch
The stock is set to report Q2 2026 earnings in the coming weeks, which will provide further clarity on the company’s ability to sustain its growth trajectory. Investors should monitor the breadth of analyst coverage and any follow-up from Raymond James or other key rating firms.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
ALHC by the numbers
Last: $14.56Session: -1.95%7 sessions: -29.39%Coverage: 3 stories / 3 sourcesAI sentiment: 59/100 (bullish)Mkt cap: $3.1BP/E: 75.252w: $12.91 to $25.12
The headlines behind the move
7d agoInvesting.com Analyst RatingsBEARISH 38Analyst
Raymond James downgrades Alignment Healthcare stock rating on earnings visibility concerns
Raymond James downgrades Alignment Healthcare stock rating on earnings visibility concerns
7d agoYahoo FinanceBULLISH 67General
Speed as Strategy: Rabigh Reinforcement Delivers 1,179 MW on an Accelerated Timeline
Facing potential supply constraints along the Makkah-Jeddah corridor, Saudi Arabia’s power sector compressed a combined cycle schedule by months driven by early alignment, staged authorization, and
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on ALHC: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier ALHC move explainers: 2026-08-04 · 2026-08-03 · 2026-07-31